TELA

0.68855.27%
GP

Guy Paul Nohra

Independent Director

Mr. Guy Paul Nohra, MBA, is Independent Director of TELA Bio, Inc. He is Independent Director at Bioventus Inc. since September 2020. He co-founded Alta Partners LP in March 1996 and serves as its Managing Director. Mr. Nohra is a Co-Founder of Alta California Partners III, L.P. and Alta California Partners IV, L.P. and serves as its Managing Director. He serves as Non-Executive Director of Sanifit Therapeutics S.A. (formerly known as Laboratoris Sanifit S.L.). since June 26, 2019. Mr. Nohra serves as an Advisor at USGI Medical, Inc. He works at City of Baltimore Development Corp. and Emerging Technology Center. He served as the General Partner of Alta Life Sciences Spain I, FCR at Altamar Private Equity SGIIC S.A.U. He served as Senior Partner at Alta V, L.P. He served as a Senior Partner at Burr, Egan, Deleage & Co. (BEDCO), Inc. He joined BEDCO in 1989 and served as its Vice President from 1989 to 1997. In his roles at BEDCO and Alta Partners, he was involved in the funding of notable medical technology and life sciences companies such as R2 Technology, DGI Resolution, Inc. (formerly deCODE genetics Inc.) and Vesica. He served as a Product Manager of Medical Products at Security Pacific Trading Corporation and was responsible for a multi-million dollar product line and traveled extensively in Korea, Taiwan, Hong Kong, China and Southeast Asia. He served as the Chairman of the Board at USGI Medical, Inc. He serves as a Director at USGI Medical, Inc. He served as a Director at Carbylan Therapeutics, Inc. since December 2005. He is Director at Bioventus LLC and was a Member of Board of Managers since May 2012. He serves as a Director of Vesica, Inc., Nanomix, Inc., Pilot Cardiovascular Systems, Inc. and InnerDyne, Inc. He served as the Chairman of ZS Pharma, Inc. until December 16, 2015. He served as a Director of VertiFlex Inc. until March 27, 2017. He served as a Director of ZS Pharma, Inc. from June 2013 to December 16, 2015. He served on the Board of Directors of the Medical Device Manufacturing Association from 2003 to 2013 and is a Board Member Emeritus. He served as a Director of AcelRx Pharmaceuticals, Inc. from August 2006 to December 10, 2013. He served as an Independent Director at Medtronic ATS Medical, Inc. (formerly ATS Medical) until August 12, 2010. Mr. Nohra served as a Director of Interpore Spine, Ltd., deCODE genetics, Inc.; Interpore International; R2 Technology, Inc. since July 1994 and First Medical, Inc. He served as a Director of KalVista Pharmaceuticals, Inc. since November 22, 2016. He served as a Director of Cutera, Inc. from November 1999 to January 2006. He served as the President of the Silicon Valley chapter of The Leukemia and Lymphoma Society from 2010 to 2013. He was named to the 2007 Forbes “Midas List“ of dealmakers in high-tech and life sciences. Mr. Nohra holds an MBA from the University of Chicago Graduate School of Business (1987-1989). He received a BA in History from Stanford University. He also received Bachelor’s degree in Economics from Standford University (1978-1982). He served as a Director of Cerenis Therapeutics, The Medical Device Manufacturers Association, Coapt Systems, Inc., Situs Corporation, Paracor Medical, Inc. and PneumRx, Inc. Mr. Nohra currently serves as a member of the boards of directors of several private life sciences companies, including Bionure, Inc. and Spiral Therapeutics, Inc.

Positions